Matches in Nanopublications for { ?s ?p "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP248720.RAaaYdITwR2sVwwfK5HDC6Ey3ZKUNO_sY0DqZKe-jYH9A130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248720.RAaaYdITwR2sVwwfK5HDC6Ey3ZKUNO_sY0DqZKe-jYH9A130_provenance.
- assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP718159.RAQ9M_mCPureI9N1xsmdMxyDzYZwFYiQyyBv8R3rNvryU130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718159.RAQ9M_mCPureI9N1xsmdMxyDzYZwFYiQyyBv8R3rNvryU130_provenance.
- NP235706.RAZjP5yVKpwecTAxS1PY9k7tjwfgB_evNRQ8YHY0Y5vqo130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235706.RAZjP5yVKpwecTAxS1PY9k7tjwfgB_evNRQ8YHY0Y5vqo130_provenance.
- NP980662.RAcgnBiPHcBdorepJtqsa5jYrNE6GJQgAuRIAZpDqXRCw130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980662.RAcgnBiPHcBdorepJtqsa5jYrNE6GJQgAuRIAZpDqXRCw130_provenance.
- NP235835.RAvEU3WdRZAz4DTg0CnRG9svh1SvZwd898BwWZxLlBitI130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235835.RAvEU3WdRZAz4DTg0CnRG9svh1SvZwd898BwWZxLlBitI130_provenance.
- NP877508.RAMRhqv96nBHjhPhTLPW3l8Q4Z42P0mCRoJ1R3AIkyn5g130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877508.RAMRhqv96nBHjhPhTLPW3l8Q4Z42P0mCRoJ1R3AIkyn5g130_provenance.
- NP235605.RAFZwrC9svxGAFts-iyV3L9LkFmxtHRwuiUJ4DeVTf4fs130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235605.RAFZwrC9svxGAFts-iyV3L9LkFmxtHRwuiUJ4DeVTf4fs130_provenance.
- NP980658.RANa6p50v23V0SMeBDrR3VzbNS_QN47-gOsOGXLVQWUko130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980658.RANa6p50v23V0SMeBDrR3VzbNS_QN47-gOsOGXLVQWUko130_provenance.
- NP980659.RA8p_7nlFlstPY7HMOgGUnAD7-zGh-IEmlMluQa3yQEiA130_assertion description "[Our findings provide new insights into the pathogenesis of ovarian cancer and identify ALK as a potential therapeutic target in a subset of serous ovarian carcinoma and stromal sarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980659.RA8p_7nlFlstPY7HMOgGUnAD7-zGh-IEmlMluQa3yQEiA130_provenance.